Damage in the ANCA-associated vasculitides: Long-term data from the European Vasculitis Study Group (EUVAS) therapeutic trials
Objectives: To describe short-term (up to 12 months) and long-term (up to 7 years) damage in patients with newly diagnosed antineutrophil-cytoplasm antibodyassociated vasculitis (AAV).
Bibliographic Details
Main Authors: |
Robson, J,
Doll, H,
Suppiah, R,
Flossmann, O,
Harper, L,
Höglund, P,
Jayne, D,
Mahr, A,
Westman, K,
Luqmani, R |
Format: | Journal article
|
Language: | English |
Published: |
BMJ Publishing Group
2015
|